Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Cancer

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

PDGFRα/β and VEGFR2 polymorphisms in colorectal cancer: incidence and implications in clinical outcome

  • Purificacion Estevez-Garcia1, 2,
  • Angel Castaño3,
  • Ana C Martin4,
  • Fernando Lopez-Rios5,
  • Joaquin Iglesias4,
  • Sandra Muñoz-Galván1,
  • Iker Lopez-Calderero1, 2,
  • Sonia Molina-Pinelo1,
  • Maria D Pastor1,
  • Amancio Carnero1,
  • Luis Paz-Ares1, 2 and
  • Rocio Garcia-Carbonero1, 2Email author
BMC Cancer201212:514

https://doi.org/10.1186/1471-2407-12-514

Received: 22 June 2012

Accepted: 28 October 2012

Published: 12 November 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
22 Jun 2012 Submitted Original manuscript
16 Aug 2012 Reviewed Reviewer Report - Takumi Ochiai
Resubmission - Version 2
Submitted Manuscript version 2
22 Aug 2012 Reviewed Reviewer Report - Takumi Ochiai
24 Aug 2012 Reviewed Reviewer Report - Torben Hansen
5 Oct 2012 Author responded Author comments - ROCIO GARCIA-CARBONERO
Resubmission - Version 3
5 Oct 2012 Submitted Manuscript version 3
9 Oct 2012 Reviewed Reviewer Report - Takumi Ochiai
18 Oct 2012 Reviewed Reviewer Report - Torben Hansen
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
28 Oct 2012 Editorially accepted
12 Nov 2012 Article published 10.1186/1471-2407-12-514

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Instituto de Biomedicina de Sevilla (IBIS) (HUVR, CSIC, Universidad de Sevilla)
(2)
Medical Oncology Department, Hospital Universitario Virgen del Rocio
(3)
Pathology Department, Hospital de Fuenlabrada
(4)
Bionostra Aplicaciones Biotecnológicas, S.L.U
(5)
Pathology Department, Centro Integral Oncológico Clara Campal

Advertisement